Retatrutide, a new drug that outperforms Ozempic, helps people to lose a quarter of their weight Read more
Capital Group purchases more than £110m worth of NatWest shares following UK Government share cuts Read more
FDA Grants Rare Pediatric Disease Designation to Imaging Biometrics’ Lead Drug Candidate IB-003 Read more